vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $40.3M, roughly 1.8× Cambium Networks Corp). Cambium Networks Corp runs the higher net margin — -17.9% vs -49.0%, a 31.1% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -23.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-84.7M).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
CMBM vs VRDN — Head-to-Head
Income Statement — Q4 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $70.6M |
| Net Profit | $-7.2M | $-34.6M |
| Gross Margin | 36.6% | — |
| Operating Margin | -28.4% | -56.7% |
| Net Margin | -17.9% | -49.0% |
| Revenue YoY | -23.2% | 81958.1% |
| Net Profit YoY | 71.0% | 54.9% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $70.6M | ||
| Q4 24 | $40.3M | — | ||
| Q3 24 | $44.7M | — | ||
| Q2 24 | $45.2M | — | ||
| Q1 24 | $47.1M | — | ||
| Q4 23 | $52.5M | — | ||
| Q3 23 | $44.6M | — | ||
| Q2 23 | $53.7M | — |
| Q3 25 | — | $-34.6M | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-34.5M | — | ||
| Q2 24 | $-14.2M | — | ||
| Q1 24 | $-18.4M | — | ||
| Q4 23 | $-24.9M | — | ||
| Q3 23 | $-36.4M | — | ||
| Q2 23 | $-13.4M | — |
| Q3 25 | — | — | ||
| Q4 24 | 36.6% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 29.8% | — | ||
| Q4 23 | 15.2% | — | ||
| Q3 23 | 26.7% | — | ||
| Q2 23 | 39.0% | — |
| Q3 25 | — | -56.7% | ||
| Q4 24 | -28.4% | — | ||
| Q3 24 | -69.6% | — | ||
| Q2 24 | -27.2% | — | ||
| Q1 24 | -33.1% | — | ||
| Q4 23 | -44.5% | — | ||
| Q3 23 | -46.2% | — | ||
| Q2 23 | -20.9% | — |
| Q3 25 | — | -49.0% | ||
| Q4 24 | -17.9% | — | ||
| Q3 24 | -77.3% | — | ||
| Q2 24 | -31.5% | — | ||
| Q1 24 | -39.2% | — | ||
| Q4 23 | -47.5% | — | ||
| Q3 23 | -81.5% | — | ||
| Q2 23 | -25.0% | — |
| Q3 25 | — | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-1.22 | — | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.66 | — | ||
| Q4 23 | $-0.90 | — | ||
| Q3 23 | $-1.32 | — | ||
| Q2 23 | $-0.49 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $67.6M | — |
| Stockholders' EquityBook value | $-3.2M | $503.0M |
| Total Assets | $173.7M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | — | ||
| Q4 24 | $67.6M | — | ||
| Q3 24 | $67.6M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | — | ||
| Q4 23 | $25.1M | — | ||
| Q3 23 | $25.8M | — | ||
| Q2 23 | $26.4M | — |
| Q3 25 | — | $503.0M | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $34.1M | — | ||
| Q1 24 | $45.0M | — | ||
| Q4 23 | $61.1M | — | ||
| Q3 23 | $82.5M | — | ||
| Q2 23 | $116.5M | — |
| Q3 25 | — | $577.1M | ||
| Q4 24 | $173.7M | — | ||
| Q3 24 | $194.3M | — | ||
| Q2 24 | $221.1M | — | ||
| Q1 24 | $219.8M | — | ||
| Q4 23 | $209.1M | — | ||
| Q3 23 | $222.4M | — | ||
| Q2 23 | $275.7M | — |
| Q3 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — | ||
| Q4 23 | 0.41× | — | ||
| Q3 23 | 0.31× | — | ||
| Q2 23 | 0.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-84.6M |
| Free Cash FlowOCF − Capex | $-10.8M | $-84.7M |
| FCF MarginFCF / Revenue | -26.8% | -120.1% |
| Capex IntensityCapex / Revenue | 1.1% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-84.6M | ||
| Q4 24 | $-10.4M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $-15.9M | — | ||
| Q4 23 | $-5.8M | — | ||
| Q3 23 | $-345.0K | — | ||
| Q2 23 | $-4.5M | — |
| Q3 25 | — | $-84.7M | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $87.0K | — | ||
| Q1 24 | $-17.4M | — | ||
| Q4 23 | $-7.4M | — | ||
| Q3 23 | $-1.5M | — | ||
| Q2 23 | $-5.2M | — |
| Q3 25 | — | -120.1% | ||
| Q4 24 | -26.8% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -37.0% | — | ||
| Q4 23 | -14.0% | — | ||
| Q3 23 | -3.3% | — | ||
| Q2 23 | -9.7% | — |
| Q3 25 | — | 0.2% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 3.3% | — | ||
| Q4 23 | 3.1% | — | ||
| Q3 23 | 2.5% | — | ||
| Q2 23 | 1.2% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
VRDN
Segment breakdown not available.
